Ventricular Assist Devices Market By Type (Right Ventricular Assist Devices, Left Ventricular Assist Devices, Bi-Ventricular Assist Devices), By Application (Bridge To Transplant (BTT), Bridge To Destination (BTD), Bridge To Recovery (BTR) ), - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Congestive heart failure is a potential life-threatening condition that weakens the heart muscles and reduces the ability to pump blood through the body. Patients’ life can be extended and improved with the use of ventricular assist devices as it is an effective alternative for heart transplant. Ventricular assist devices are mechanical instruments that improves the pumping of blood and maintain efficient flow throughout the body. Rising number of geriatric population with cardiac complication, lifestyle change with increasing consumption of junk food, binge drinking and drug abuse are responsible for the rise in lifestyle diseases like cardiovascular, diabetes and stroke. Increasing number cardiovascular surgical procedures will result into deep market penetration of the ventricular assist devices.

For the purpose of this study, the various types studied include left ventricular assist device, right ventricular assist device and bi-ventricular assist device. The ventricular assist devices applications are further categorized as bridge to transplant, bridge to destination and bridge to recovery. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global ventricular assist device market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The regions are also further sub-segmented on the basis of, cross-sectional study by device, application and major countries. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global ventricular assist devices market. Competition assessment tools such as Porter’s five forces analysis, market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global ventricular assist devices market. The key players profiled in this report are Abiomed, Berlin Heart GmbH, Cardiac Assist, Inc., HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., St. Jude Medical, LLC., Sun Medical Technology Research Corp., Syncardia System Inc. and Thoratec Corporation.

Ventricular Assist Devices Market

Based on application areas, the global ventricular assist devices market is categorized into

  • Bridge to Transplant (BTT)
  • Bridge to Destination (BTD)
  • Bridge to Recovery (BTR)

ventricular-assist-devices-market

According to the European Society of Cardiology (ESC), 17%-45% of heart failure patients admitted in hospitals worldwide die within 1 year of admission. The British Heart Foundation (BHF) claims that the causative agent for heart failure are heart valve problems, abuse of alcohol or recreational drugs, arrhythmia, congenital heart disease, viral infection of the heart muscles etc. In 2016, bridge to transplant segment dominated the application market significantly due to factors such as rising prevalence of congestive heart failure and increasing number of patients which showed failure in optimal medical management and are at a risk of imminent death and require immediate heart transplantation. Bridge to destination segment will be the fastest growing segment in the application market throughout the forecast period 2017-2025, majorly due to factors such as large number of patients are deemed too old for a heart transplant, compromised immunity, left ventricular ejection fraction less than 25% and can survive with a LVAD throughout their lifespan. Bridge to recovery offers a lucrative market opportunities as it is finding huge application in patients with temporary heart failure, patients recovering from heart surgery get VAD implanted until the heart is strong enough to pump blood.

For the purpose of this study, the global ventricular assist devices market is categorized into the following regional and country specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Ventricular Assist Devices Market

North America was observed to be the largest market for ventricular assist devices in the base year 2016. According to the Centers for Disease Control and Prevention about 610,000 Americans die each year due to heart disease, which represents 1 in every 4 deaths. The dominance of North America is mainly attributed to rise in lifestyle diseases such as cardiovascular disease, stroke and chronic pulmonary hypertension, shift in lifestyle with increased drug abuse, binge drinking and consumption of fast food and evolved reimbursement scenario favoring ventricular assist devices use. According to the European Cardiovascular Disease Statistics - 2017, each year CVD causes 3.9 million deaths in Europe and 1.8 million deaths in the European Union. The market growth in Europe is chiefly attributed to increasing number of patients suffering with cardiovascular complications, and supportive regulatory approval for ventricular assist devices market. Asia Pacific will be the fastest growing regional segment throughout the forecast period 2017-2025. Factors that propel the market growth are rising prevalence of geriatric population suffering from cardiac complication, increasing healthcare expenditure in these regions and increasing disposable incomes. Factors such as developing health infrastructure, increasing awareness and increasing demand for ventricular assist devices are going to fuel the rapid growth of ventricular assist devices market in Latin America, and Middle East and Africa region in the near future.   

Choose License Type
Published Date:  Jul 2017
Category:  Medical Devices
Report ID:   58590
Report Format:   PDF
Pages:   120
Rating:    4.1 (55)
Connect With Us
+1-408-641-3282
24/7 Research Support